Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 918123, 8 pages
Research Article

Resveratrol Prevents Cardiovascular Complications in the SHR/STZ Rat by Reductions in Oxidative Stress and Inflammation

School of Medical and Applied Sciences, Central Queensland University, Building 81, Bruce Highway, Rockhampton, QLD 4701, Australia

Received 29 August 2014; Accepted 10 October 2014

Academic Editor: Hyun-Ock Pae

Copyright © 2015 Rebecca K. Vella et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [12 citations]

The following is the list of published articles that have cited the current article.

  • Lijie Ma, Yilin Zhao, Ruixuan Wang, Tingting Chen, Wangping Li, Yandong Nan, Xueying Liu, and Faguang Jin, “3,5,4′-Tri-O-acetylresveratrol Attenuates Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome via MAPK/SIRT1 Pathway,” Mediators of Inflammation, vol. 2015, pp. 1–12, 2015. View at Publisher · View at Google Scholar
  • Sandra Maria Barbalho, Márcia Rocha Gabaldi, Rodrigo Galhardi Gasparini, Ricardo De Alvares Goulart, Marcelo Dib Bechara, Gabriela Lombardi Dos Santos Almeida Batista, and Karina Quesada, “Oxidative aspects of metabolic syndrome and atherosclerosis,” Scientia Medica, vol. 25, no. 3, pp. 1–7, 2015. View at Publisher · View at Google Scholar
  • Hnin Ei Phyu, Jordon Candice Irwin, Rebecca Kate Vella, and Andrew Stuart Fenning, “Resveratrol shows neuronal and vascular-protective effects in older, obese, streptozotocin-induced diabetic rats,” British Journal Of Nutrition, vol. 115, no. 11, pp. 1911–1918, 2016. View at Publisher · View at Google Scholar
  • Jinxia Gu, Yingjie Lu, Xiaoyun Wang, Lan Zhang, He Li, Xian Liu, and Zhongqiao Ren, “Effects of Diabetic Hyperglycemia on Central Ang-(1-7)-Mas-R-nNOS Pathways in Spontaneously Hypertensive Rats,” Cellular Physiology and Biochemistry, vol. 40, no. 5, pp. 1186–1197, 2016. View at Publisher · View at Google Scholar
  • Omolola R. Oyenihi, Ayodeji B. Oyenihi, Anne A. Adeyanju, and Oluwafemi O. Oguntibeju, “Antidiabetic Effects of Resveratrol: The Way Forward in Its Clinical Utility,” Journal of Diabetes Research, vol. 2016, pp. 1–14, 2016. View at Publisher · View at Google Scholar
  • Guangxi Wang, Zhiqiang Hu, Qiuting Fu, Xu Song, Qiankun Cui, Renyong Jia, Yuanfeng Zou, Changliang He, Lixia Li, and Zhongqiong Yin, “Resveratrol mitigates lipopolysaccharide-mediated acute inflammation in rats by inhibiting the TLR4/NF-κBp65/MAPKs signaling cascade,” Scientific Reports, vol. 7, pp. 45006, 2017. View at Publisher · View at Google Scholar
  • Xiao-Dan Zhu, Wen-Bin Dong, and Xiao-Ping Lei, “Resveratrol as a potential therapeutic drug for respiratory system diseases,” Drug Design, Development and Therapy, vol. 11, pp. 3591–3598, 2017. View at Publisher · View at Google Scholar
  • Ebru Öztürk, Ayşe Kübra Karaboğa Arslan, Mükerrem Betül Yerer, and Anupam Bishayee, “Resveratrol and diabetes: A critical review of clinical studies,” Biomedicine & Pharmacotherapy, vol. 95, pp. 230–234, 2017. View at Publisher · View at Google Scholar
  • Rebecca K. Vella, Douglas J. Jackson, and Andrew S. Fenning, “ Δ 9 -Tetrahydrocannabinol Prevents Cardiovascular Dysfunction in STZ-Diabetic Wistar-Kyoto Rats ,” BioMed Research International, vol. 2017, pp. 1–10, 2017. View at Publisher · View at Google Scholar
  • Kirsty MacRae, Kylie Connolly, Rebecca Vella, and Andrew Fenning, “Epicatechin’s cardiovascular protective effects are mediated via opioid receptors and nitric oxide,” European Journal of Nutrition, 2018. View at Publisher · View at Google Scholar
  • Asmaa Mohammed ShamsEldeen, Hend Ashour, Heba Samy Shoukry, Mostafa Fadel, Samaa Samir Kamar, Marwan Aabdelbaset, Laila Ahmed Rashed, and Hania Ibrahim Ammar, “Combined treatment with systemic resveratrol and resveratrol preconditioned mesenchymal stem cells, maximizes antifibrotic action in diabetic cardiomyopathy,” Journal of Cellular Physiology, 2018. View at Publisher · View at Google Scholar
  • Zhi-Dong Ge, Qingquan Lian, Xiaowen Mao, and Zhengyuan Xia, “Current Status and Challenges of NRF2 as a Potential Therapeutic Target for Diabetic Cardiomyopathy,” International Heart Journal, 2019. View at Publisher · View at Google Scholar